The ChEMBL database in 2017

被引:1570
作者
Gaulton, Anna [1 ]
Hersey, Anne [1 ]
Nowotka, Michal [1 ]
Bento, A. Patricia [1 ,2 ]
Chambers, Jon [1 ]
Mendez, David [1 ]
Mutowo, Prudence [1 ]
Atkinson, Francis [1 ]
Bellis, Louisa J. [1 ,3 ]
Cibrian-Uhalte, Elena [1 ]
Davies, Mark [1 ,4 ]
Dedman, Nathan [1 ,5 ]
Karlsson, Anneli [1 ,4 ]
Magarinos, Maria Paula [1 ,2 ]
Overington, John P. [1 ,4 ]
Papadatos, George [1 ,6 ]
Smit, Ines [1 ]
Leach, Andrew R. [1 ]
机构
[1] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Hinxton CB10 1SD, Cambs, England
[2] Open Targets, Wellcome Genome Campus, Hinxton CB10 1SD, Cambs, England
[3] Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England
[4] BenevolentAI, 40 Churchway, London NW1 1LW, England
[5] Local Measure, 87 Leonard St, London EC2A 4QS, England
[6] GlaxoSmithKline, Med Res Ctr, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England
基金
英国惠康基金; 美国国家卫生研究院;
关键词
BIOASSAY ONTOLOGY BAO; DRUG DISCOVERY; MEDICINAL CHEMISTRY; SCREENING LIBRARIES; NEGLECTED DISEASES; ATTRITION RATES; UNITED-STATES; PHASE-II; TARGET; SAFETY;
D O I
10.1093/nar/gkw1074
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ChEMBL is an open large-scale bioactivity database (https://www.ebi.ac.uk/chembl), previously described in the 2012 and 2014 Nucleic Acids Research Database Issues. Since then, alongside the continued extraction of data from the medicinal chemistry literature, new sources of bioactivity data have also been added to the database. These include: deposited data sets from neglected disease screening; crop protection data; drug metabolism and disposition data and bioactivity data from patents. A number of improvements and new features have also been incorporated. These include the annotation of assays and targets using ontologies, the inclusion of targets and indications for clinical candidates, addition of metabolic pathways for drugs and calculation of structural alerts. The ChEMBL data can be accessed via a web-interface, RDF distribution, data downloads and RESTful web-services.
引用
收藏
页码:D945 / D954
页数:10
相关论文
共 58 条
  • [1] Evolving BioAssay Ontology (BAO): modularization, integration and applications
    Abeyruwan, Saminda
    Vempati, Uma D.
    Kuecuek-McGinty, Hande
    Visser, Ubbo
    Koleti, Amar
    Mir, Ahsan
    Sakurai, Kunie
    Chung, Caty
    Bittker, Joshua A.
    Clemons, Paul A.
    Brudz, Steve
    Siripala, Anosha
    Morales, Arturo J.
    Romacker, Martin
    Twomey, David
    Bureeva, Svetlana
    Lemmon, Vance
    Schuerer, Stephan C.
    [J]. JOURNAL OF BIOMEDICAL SEMANTICS, 2014, 5
  • [2] [Anonymous], 2014, Challenges
  • [3] Phase II and Phase III attrition rates 2011-2012
    Arrowsmith, John
    Miller, Philip
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (08) : 568 - 568
  • [4] New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
    Baell, Jonathan B.
    Holloway, Georgina A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (07) : 2719 - 2740
  • [5] DRUG SAFETY DISCONTINUATIONS IN THE UNITED-KINGDOM, THE UNITED-STATES, AND SPAIN FROM 1974 THROUGH 1993 - A REGULATORY PERSPECTIVE
    BAKKE, OM
    MANOCCHIA, M
    DEABAJO, F
    KAITIN, KI
    LASAGNA, L
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (01) : 108 - 117
  • [6] The ChEMBL bioactivity database: an update
    Bento, A. Patricia
    Gaulton, Anna
    Hersey, Anne
    Bellis, Louisa J.
    Chambers, Jon
    Davies, Mark
    Krueger, Felix A.
    Light, Yvonne
    Mak, Lora
    McGlinchey, Shaun
    Nowotka, Michal
    Papadatos, George
    Santos, Rita
    Overington, John P.
    [J]. NUCLEIC ACIDS RESEARCH, 2014, 42 (D1) : D1083 - D1090
  • [7] Blake James F, 2005, Med Chem, V1, P649, DOI 10.2174/157340605774598081
  • [8] Lessons learnt from assembling screening libraries for drug discovery for neglected diseases
    Brenk, Ruth
    Schipani, Alessandro
    James, Daniel
    Krasowski, Agata
    Gilbert, Ian Hugh
    Frearson, Julie
    Wyatt, Paul Graham
    [J]. CHEMMEDCHEM, 2008, 3 (03) : 435 - 444
  • [9] Getting pharmaceutical R&D back on target
    Bunnage, Mark E.
    [J]. NATURE CHEMICAL BIOLOGY, 2011, 7 (06) : 335 - 339
  • [10] Carnitine Palmitoyltransferase (CPT) Modulators: A Medicinal Chemistry Perspective on 35 Years of Research
    Ceccarelli, Simona M.
    Chomienne, Odile
    Gubler, Marcel
    Arduini, Arduino
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (09) : 3109 - 3152